Myelodysplastic Syndrome Clinical Trial
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Summary
The purpose of this study is to learn about the impact that the services and programs provided by the Leukemia and Lymphoma Society have among patients with blood cancer, such as access to care, quality of life, and financial burden.
Eligibility Criteria
Inclusion Criteria:
Be currently receiving primary or relapse treatment for a diagnosis of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
Report experiencing at least one unmet need addressed by the LLS Program (i.e., medical care including second opinions, travel for care, clinical trial access, financial and insurance needs, supportive programs, disease and treatment education)
Not be currently participating in any LLS programs or services
Be willing to be followed for 6 months
Speak English or Spanish
Exclusion Criteria:
Are not receiving primary or relapse treatment for a diagnosis of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
Are not experiencing unmet needs addressed by the LLS Program (i.e., medical care including second opinions, travel for care, clinical trial access, financial and insurance needs, supportive programs, disease and treatment education)
Are currently participating in any LLS programs or services
Are not willing to be followed for 6 months
Do not speak English or Spanish.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Miami Florida, 33136, United States More Info
Principal Investigator
Chicago Illinois, 60637, United States More Info
Principal Investigator
San Antonio Texas, 78229, United States More Info
Principal Investigator
How clear is this clinincal trial information?
